DUKE Robotics Corp. annual report, FY2021

Business context and reporting period

The supplied filing is UAS Drone Corp.’s Form 10-K for the fiscal year ended December 31, 2021, filed March 7, 2022. Although the request identifies DUKE Robotics Corp., the filing names UAS Drone Corp. as the registrant; Duke Robotics, Inc. is its wholly owned subsidiary. This is an annual report, not a standalone fourth-quarter report.

The company is an early-stage robotics developer focused on TIKAD, a stabilization system designed for remote precision firing of small arms and light weapons. In January 2021, its Israeli subsidiary granted Elbit Systems Land a worldwide exclusive license for military, defense, homeland security and paramilitary marketing, sales, production and further development. The company reported no TIKAD unit sales in 2021; reported revenue came from an upfront fee for engineering-material transfer and support under the Elbit agreement.

Financial results and liquidity

Amounts below are in U.S. dollars. The audited statements present figures in thousands, except per-share data.

The reported gross profit equals revenue because the statements show no cost of revenue; this does not establish that future unit sales will have comparable margins. No meaningful operating margin is established by these results.

Cash and cash equivalents were $3.560 million at year-end, versus $105,000 a year earlier. Working capital improved to $3.389 million from a deficit of $1.176 million. Operating cash use was $234,000; financing provided $3.689 million, producing a $3.455 million increase in cash. The company reported $297,000 of stockholder loans, no outstanding bank loans, and no convertible loans at year-end. Accumulated losses were $6.019 million; stockholders’ equity was $3.101 million.

Material changes versus 2020

• Revenue rose from zero to $500,000, but there were no TIKAD unit sales; the revenue was an upfront Elbit-related fee.
• Net loss narrowed by $480,000. General and administrative expense fell by $279,000, including a $229,000 decrease in stock-based compensation.
• Financing expense increased to $446,000 from $63,000, primarily due to interest and costs associated with previously outstanding convertible loans.
• Cash rose substantially following 2021 financing and revenue. The company sold 12.5 million shares at $0.40 and issued warrants for a further 12.5 million shares at a $0.40 exercise price, for approximately $5 million gross proceeds.
• Outstanding convertible debt was repaid or converted during 2021. Year-end stockholder loans remained outstanding and carry conditions on repayment, including fundraising and earnings thresholds.

Outlook, risks and other notable items

• Funding and going concern: Management said available funds were sufficient for its plans for the 12 months following issuance of the financial statements, but also said it intends to seek additional funding and cannot determine when sustainable profits may be achieved. The filing describes substantial doubt about going concern at year-end 2020; the 2021 statements report improved liquidity.
• Commercialization: Elbit’s agreement provides for tiered royalties on TIKAD sales and potential investment in development and production, subject to milestones and Elbit’s discretion. No TIKAD units or evaluation-project revenue were reported for 2021. The company’s revenue outlook is not quantified.
• Key risks: Limited operating history and commercialization; dependence on future financing and government customers; defense marketing and export approvals; competition and manufacturing scale-up; reliance on suppliers; intellectual-property protection; product liability; and political, security, currency and operational risks in Israel. The company also identifies COVID-19-related supply, travel and funding uncertainty.
• Controls: Management concluded disclosure controls and internal control over financial reporting were not effective at December 31, 2021, citing limited accounting personnel and segregation of duties, lack of full-time CEO/CFO oversight of daily operations and financial reporting, and no independent audit committee. The auditor did not attest to internal-control effectiveness.
• Legal matter: A 2018 dispute involving a former service provider was settled in June 2021; the filing says the company and Duke incurred no liability. A separate former-vendor settlement was also reported in 2021.
• Capital structure and governance: 54,018,813 common shares were outstanding as of March 7, 2022. The company reported limited OTCQB trading liquidity, no independent directors, and no audit or compensation committee. A 2021 equity plan authorizes up to 4.8 million awards; 2,426,812 options were outstanding at year-end.

Important facts for investors to verify

1. Confirm the issuer identity and corporate relationship: the filing is for UAS Drone Corp., not an entity named DUKE Robotics Corp.
2. Review the Elbit agreement’s royalty tiers, termination and investment conditions, and whether commercialization has progressed beyond the 2021 upfront fee; no TIKAD units were sold that year.
3. Reconcile offering proceeds and issuance costs: the filing cites approximately $5 million gross proceeds, while the equity statement reports $3.930 million net of $1.070 million issuance expenses and the cash-flow statement reports $4.649 million of share proceeds.
4. Assess cash runway, further financing needs, and repayment terms for the $297,000 stockholder-loan balance, including the stated fundraising and EBITDA conditions.
5. Track remediation of the disclosed material weaknesses and any changes in governance, financial-reporting controls, staffing or independent oversight.
6. Review potential dilution from warrants, options and the equity plan, alongside the company’s share count and trading liquidity.